Evaluation of Cervical Cancer Screening in Japan: Challenges and Future Directions for Negative Intraepithelial Lesion or Malignancy/High-Risk Human Papillomavirus Positive Case Management

Evaluation of Cervical Cancer Screening in Japan: Challenges and Future Directions for Negative Intraepithelial Lesion or Malignancy/High-Risk Human Papillomavirus Positive Case Management

Cervical cancer screening is crucial for early detection and prevention. In Japan, women with negative intraepithelial lesion or malignancy (NILM) and high-risk human papillomavirus (HR-HPV) positivity are recommended retest for 12 months, rather than immediate colposcopy. International guidelines d...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasushi Umezaki, Asako Fukuda, Makiko Kurihara, Mariko Hashiguchi, Kaoru Okugawa, Masatoshi Yokoyama
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Current Oncology
Subjects:
cervical cancer screening
HR-HPV
NILM/HR-HPV+
colposcopy
Japan healthcare policy
Online Access:https://www.mdpi.com/1718-7729/32/6/295
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1718-7729/32/6/295

Similar Items